DCDario CattaneoPharmD, PhDSlidesetHIVRSVLiverpool Course 2021Liverpool Course 2021 - Dr. Dario Cattaneo - Case 2: The Patient with Multiple Comorbidities. The Case for De-PrescribingView Slideset
SKSaye KhooMD, PhDSlidesetHIVRSVLiverpool Course 2021Liverpool Course 2021 - Dr. Saye Khoo - Case 1: ARV Absorption in a Patient Undergoing Bowel SurgeryView Slideset
MBMarta BoffitoMD, PhD, FRCP, MBASlidesetHIVRSVLiverpool Course 2021Liverpool Course 2021 - Dr. Marta Boffito - Clinical Pharmacology of Long-Acting Therapy: Focus on Understudied PopulationsView Slideset
GDPGiovanni Di PerriMD, PhDSlidesetHIVRSVLiverpool Course 2021Liverpool Course 2021 - Dr. Giovanni Di Perri - Clinical Pharmacology of 2 Drug RegimensView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Pharmacokinetic Modeling and Simulation of the Interaction between Moxifloxacin and Rifapentine in Healthy Volunteers | M. ImperialView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Rifampin vs. Rifapentine: a debate over the preferred rifamycin | Kelly Dooley, MD, PhDView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Population pharmacokinetic modeling to assess the non-linear increase in exposure following increasing doses of rifampicin | R. SvenssonView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Population Pharmacokinetics of AZD5847 in Adults with Pulmonary Tuberculosis | C. PeloquinView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016A new model for early clinical development of TB drugs and its application to Q203 and BTZ043 | Norbert Heinrich, MDView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016A model-based analysis to describe bedaquiline’s exposure-response relationship and predict the impact of drug-drug interactions | E. SvenssonView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Exploration of Non-Replicating Mycobacterium Tuberculosis In Vitro System Through Mathematical Modelling | A. SchipaniView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016High drug tolerance of Mycobacterium tuberculosis in caseum | J. SarathyView Slideset
